ABSTRACT

Herbals and nutraceuticals are collective terms that refer to any product obtained from a natural or food source. Nutraceuticals are herbal powders or capsules created from vitamins, minerals, and plants that have unique therapeutic qualities that aid in the prevention and treatment of disease. Herbal medicines are preferable to conventional pharmaceuticals because they are less expensive, have less side effects, and incorporate a natural healing process for boosting the immune system. The market for herbal nutraceuticals would be considerably impacted by the growth of herbal medicines and their medical products. By 2026, the Global Herbal Nutraceuticals Market is estimated to reach $64.3 billion, growing at a 11.4% compound annual growth rate during the forecast period. The major purpose of this study is to get an understanding of the herbal and nutraceutical marketing authorization/registration procedure in emerging markets, including India, Singapore, and Saudi Arabia. In general, there is no specific regulation/guidance document for this product worldwide; nonetheless, different nations have unique registration methods; so, this study provides an overview of the registration procedures in the aforementioned countries. Comparative analysis enables an understanding of the numerous distinctions between emerging market registration processes. The primary objective is to gain a better understanding of the influence of regulatory and quality requirements on the herbal and nutraceutical product registration process in emerging markets. Keywords: Herbals, India, Marketing Authorization, Nutraceuticals, Singapore, Saudi Arabia
Publication date: 01/12/2022

https://ijbpas.com/pdf/2022/December/MS_IJBPAS_2022_6654.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2022/11.12.6654